Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Normal Renal Function

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 551 participants.

Also called NCT03001817

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 551 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03001817
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Belarus, Bulgaria, Czechia, Georgia, Hungary, Poland, Russia, Ukraine (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03001817. Randomized; triple masking; primary purpose treatment. Start 2016-11-28 (actual); primary completion 2019-06-24 (actual). Results posted on 2022-11-30.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Normal Renal Function
Condition
Severe Hypertriglyceridemia
Intervention (Drug)
K-877
Intervention (Drug)
Fenofibrate
Intervention (Drug)
Placebo (for K-877)
Intervention (Drug)
Placebo (for Fenofibrate)
Lead sponsor
Kowa Research Institute, Inc. (class: industry)

Record details

Record id
cardio:ct-nct03001817
Content hash
9956d4d154c72f03e911c201981e2b3aa915af1a4b6841e261fe7a7e13f0a0a9